Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease.

ABSTRACT:

Background

The new coronavirus 19 disease (COVID-19) represents the current worldwide emergency. According to past evidence, a simple biomarker, such as low free triiodothyronine (fT3) levels, within the framework of euthyroid sick syndrome (ESS), might help to identify patients with unfavourable outcomes.

Objective

Evaluation of ESS significance in hospitalized mild COVID-19 patients.

Design

Prospective study, from 1 April 2020 to 31 May 2021.

Participants

COVID-19 patients with mild disease at hospital admission.

Main measures

At hospital admission, eligible patients underwent a complete thyroid function evaluation. Subjects with previous thyroid disease or with thyroid-interfering medications were excluded. Levels of fT3 were correlated to biochemical

SUBMITTER: Sparano C 

PROVIDER: S-EPMC8632565 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature